Log in
Pharmacology · Hormone preparations, their synthetic substitutes, and antagonists

Dopaminergics

Bromocriptinum, Cabergolinum

Dopaminergic drugs are a group of medications that stimulate dopamine receptors in the central nervous system. In endocrinology, they are used primarily to suppress the excessive secretion of prolactin and growth hormone, replacing the physiological action of endogenous dopamine.

The dopamine problemThe hormone itself does not cross the blood-brain barrier and has too short a duration of action for therapeutic use.
Main targetLactotroph and somatotroph cells of the anterior pituitary gland.
CabergolineActs from 7 to 28 days due to high receptor selectivity.
Side effectsStrictly depend on the localization of the stimulated receptors in brain structures and blood vessels.
4 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Why isn't regular dopamine used?

Endogenous dopamine performs a vital physiological function in endocrine regulation. At the level of the anterior pituitary, it acts as a natural brake: it suppresses the incretion of prolactin (lactotropic hormone) and reduces the production of growth hormone (somatotropic hormone, GH).

It would seem logical to use dopamine itself in the presence of an excess of these hormones. However, the native hormone has strict pharmacological limitations and is not used to correct endocrine disorders. There are two reasons for this: it has an extremely short duration of action and is completely incapable of crossing the blood-brain barrier (BBB). To solve this problem, pharmacology uses dopamine receptor agonists—drugs that mimic the action of the natural mediator but lack its pharmacokinetic drawbacks.

Bromocriptine: the classical approach

Bromocriptinum is a classical representative of the group, being a semisynthetic derivative of ergot alkaloids. Its pharmacodynamics is based on the direct stimulation of postsynaptic dopamine receptors in the central nervous system.

The drug effectively reduces the pathological secretion of prolactin and GH, and also possesses pronounced antiparkinsonian activity.

Indications for use:

  • Acromegaly (prescribed in situations where surgical treatment is impossible for any reason).
  • Hyperprolactinemic states accompanied by galactorrhea and prolactin-dependent amenorrhea.
  • The need for medical cessation of physiological lactation.

Strict contraindications for administration include severe forms of arterial hypertension, occlusive vascular disease, and Huntington's chorea.

Test your knowledge on the topicTasks from the «Pharmacology» course bank — instant answers and explanations.

Side effects of bromocriptine

Since bromocriptine acts non-selectively, its use is often accompanied by side effects. Their pathogenesis is directly related to the localization of stimulated receptors in various body structures:

  • Trigger zone of the vomiting center: activation of this area naturally causes nausea and vomiting.
  • Cerebral cortex: excessive stimulation can provoke psychotic reactions, including delusions and hallucinations.
  • Extrapyramidal system: interference with its function leads to the development of motor disorders—dyskinesias.
  • Peripheral circulation: the drug causes orthostatic reactions and peripheral arterial spasm. Clinically, this spasm often manifests as painful calf muscle cramps.

Other, less specific adverse reactions include dry mouth and constipation.

Cabergoline: a modern alternative

Cabergolinum (best known under the trade name Dostinex) is a modern drug that is superior to bromocriptine in many ways.

Its key difference lies in high selectivity—cabergoline is a selective $D_2$ receptor agonist. The second important advantage is a significantly longer duration of action. After taking the drug, the hypoprolactinemic effect persists for 7–28 days, making therapy much more convenient for the patient.

It is important to consider the dose-dependent nature of cabergoline's effects:

  • When used in therapeutic doses, the drug works with maximum precision, inhibiting the secretion exclusively of lactotroph cells of the pituitary.
  • When prescribed in high doses, selectivity decreases, and the patient develops systemic effects of central $D_2$ receptor stimulation.

Indications for the use of cabergoline are completely analogous to those for bromocriptine.

Briefly: answers to topical questions

What is the mechanism of the antiparkinsonian action of bromocriptine?

The antiparkinsonian effect of bromocriptine is due to the direct stimulation of dopamine receptors in the CNS. The drug causes direct excitation of dopamine receptors in the neostriatum without prior metabolic conversion.

What other drugs belong to the group of dopamine receptor agonists?

The group of dopamine receptor agonists includes:

  • Cabergoline — a selective D2 receptor agonist.
  • Pramipexole — an agonist stimulating D2 and D3 receptors.
  • Pergolide — a D1 and D2 receptor agonist, an ergot alkaloid derivative.
How to memorize

To remember the side effects of non-selective dopaminergic drugs, recall the acronym PERC: Periphery (vascular spasm, orthostasis), Extrapyramidal system (dyskinesias), Retinum / Vomiting center (nausea), Cortex (psychosis).

Class and exam questions

Why doesn't native dopamine treat hyperprolactinemia?

It does not cross the blood-brain barrier and is degraded in the body too quickly to provide a sustained therapeutic effect.

What is the main advantage of cabergoline over bromocriptine?

Cabergoline acts selectively on $D_2$ receptors and works much longer—its effect lasts up to 4 weeks, whereas bromocriptine requires frequent administration.

Why does taking bromocriptine cause calf cramps?

The drug stimulates dopamine receptors in the peripheral circulation, causing arterial spasm, which clinically manifests as calf muscle cramps.

How does the dose of cabergoline affect its selectivity?

In standard therapeutic doses, it affects only the lactotroph cells of the pituitary. When the dose is increased, selectivity is lost, and the effects of general central $D_2$ receptor stimulation occur.

Something unclear? Ask the AIThe AI tutor has read the material on "Dopaminergic drugs" and will explain it in simple terms.

What else to study on this topic

  • Mechanisms regulating the secretion of trophic hormones of the anterior pituitary gland.
  • Pharmacotherapy of acromegaly: the place of dopaminergic drugs in clinical practice.
  • Antiparkinsonian activity of ergot alkaloid derivatives.
  • Pathogenesis of dyskinesias during extrapyramidal system stimulation.
  • Occlusive vascular diseases as a contraindication to the administration of ergot alkaloids.

Master the entire topic in the «Pharmacology» course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Dopaminergic drugs" and another 5,304 pages of the subject
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 116 video lessons on the subject

Other topics in the section "Hormone preparations, their synthetic substitutes, and antagonists"

Entire section "Hormone preparations, their synthetic substitutes, and antagonists"

Free video lessons: pharmacologyShort lessons with study notes — no registration required.

Watch lessons

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.